Polar Capital Holdings Plc 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 6:00 pm Sale |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
Polar Capital Holdings Plc | 2,711,163 4.090% |
-424,708 (-13.54%) |
Filing |
| 2024-02-13 09:41 am Purchase |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Polar Capital Holdings Plc | 3,135,871 5.730% |
3,135,871 (New Position) |
Filing |